ACXP Stock Summary and Trading Ideas (Acurx Pharmaceuticals | NASDAQ:ACXP)

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Acurx Pharmaceuticals trades on the NASDAQ stock market under the symbol ACXP.

As of March 16, 2026, ACXP stock price climbed to $4.81 with 9,399,711 million shares trading.

ACXP has a beta of 0.25, meaning it tends to be less sensitive to market movements. ACXP has a correlation of 0.00 to the broad based SPY ETF.

ACXP has a market cap of $12.25 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, ACXP traded as high as $176.40 and as low as $1.33.

The top ETF exchange traded funds that ACXP belongs to (by Net Assets): VXF.

ACXP has underperformed the market in the last year with a return of -47.5%, while SPY returned +22.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ACXP shares. However, ACXP has outperformed the market in the last 3 month and 2 week periods, returning +18.2% and +220.7%, while SPY returned -1.6% and -2.5%, respectively. This indicates ACXP has been having a stronger performance recently.

ACXP support price is $3.48 and resistance is $4.28 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACXP shares will trade within this expected range on the day.